Literature DB >> 17262701

Germs on a plane: aircraft, international travel, and the global spread of disease.

Andrew T Pavia.   

Abstract

Mesh:

Year:  2007        PMID: 17262701      PMCID: PMC7109684          DOI: 10.1086/511439

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
The impact of air travel on the spread of infectious diseases has led to considerable concern but limited study [1, 2]. More than 1 billion people travel by air each year. In a recent fanciful adventure film, Snakes on a Plane, passengers are terrorized by venomous snakes. In reality, more travelers are likely to be afraid of virulent infectious organisms on their flight. There are several important ways in which air travel can influence the global spread of emerging and established infectious disease. Infections may be spread on the aircraft through close contact and large droplets [1]; airborne spread through small-particle aerosols, as in the case of severe acute respiratory syndrome (SARS) [3]; or even through contaminated food [4, 5]. Aircraft can transport infected disease vectors, such as rats or malaria-infected mosquitoes, as nonpaying passengers. Perhaps the greatest concern for global health, however, is the ability of a person with a contagious illness to travel to virtually any part of the world within 24 h. The importance of air travel for the spread of seasonal influenza was recently demonstrated by empirical data showing that the spread of influenza was delayed by the decrease in air travel after the attacks of 11 September 2001 [6]. With the current heightened awareness of pandemic influenza raised by the avian pandemic of H5N1 influenza, it is timely to reconsider the role played by air travel in the global spread of infectious diseases. In this issue of Journal of Infectious Diseases, Luna et al. [7] report on a detailed search, using extensive molecular and conventional methods, for the etiology of respiratory illness among travelers arriving in Germany who fulfilled the case definition for suspected or probable SARS. The 155 adults and children studied were infected with a wide variety of respiratory viruses and atypical bacteria. A pathogen was recovered in 44% of patients; none were infected with SARS coronavirus (CoV). Human parainfluenza virus and influenza virus were most common and were recovered from 15.5% and 14.2% of ill travelers. Other pathogens included adenovirus, non-SARS human CoV, rhinovirus, human metapneumovirus, respiratory syncytial virus, Mycoplasma pneumoniae, and Legionella species. The authors did not determine whether there was spread of these infections to fellow passengers, but there are several implications of these findings that we should consider. First, case definitions of respiratoryillness based on epidemiological characteristics and clinical symptoms are extremely nonspecific. It will be extremely difficult to identify travelers with a specific respiratory infection of concern—such as SARS, tuberculosis, or avian influenza— against the wide backdrop of other respiratory infections with overlapping symptoms. Even in the case of an emerging influenza pandemic, where the new virus is prevalent, the positive predictive value of a case definition will be low. Quarantine measures based on the screening of airline passengers are likely to cause a great deal of economic disruption and limited impact unless they can be linked with accurate and rapid diagnostic tests. Second, our understanding of the spread of respiratory infections on aircraft is very limited. Key questions include how often transmission can occur by contaminated surfaces, large droplet spread, and airborne spread of small-particle aerosols, as well as the risk for specific organisms. The scientific uncertainty limits the ability to design preventive measures. Three studies of in-flight influenza transmission have been reported, as reviewed by Mangili and Gendreau [1]. In 2 of these outbreaks, there were relatively high attack rates, but older aircraft [8] and long periods when passengers were on board with an inoperative air handling system [9] limited the generalizability of these outbreaks to modern air travel. During the SARS outbreak, investigations were conducted among passengers who traveled on 40 flights with patients on board who had symptomatic SARS. Transmission is thought to have occurred on board 5 of 40 flights. On 4 flights, a small number of suspected infections occurred among persons seated within a few rows of the index patient, consistent with spread by large droplets. However, on 1 flight from Hong Kong to Beijing, 22 of 120 passengers and crew were thought to have become infected, which suggests airborne spread over a considerable distance [3]. Many commercial aircraft use vertical airflow and high-efficiency particulate air (HEPA) filters that should limit exposure to small airborne particles. However, there are no regulations requiring HEPA filters or for testing of the function of filters [10]. In the investigation by Luna et al., the 155 travelers meeting the case definition for SARS arrived in Germany on 146 flights over the course of 69 different days. The number of potentially exposed travelers was not determined but was likely >20,000. Tracking, identifying, and treating these travelers would be extraordinarily difficult. There are a number of things that can and should be done. We need additional careful epidemiological investigations to understand the frequency and relative importance of different modes of transmission on board aircraft for specific pathogens. We should study the effectiveness of potential interventions, including standardizing air handling, requiring HEPA filtration, and providing better modes of hand hygiene. To screen arriving or departing passengers effectively, accurateand rapid diagnostics would need to be developed to complement case definitions. The ability to track exposed travelers after an important incident could be improved with better databases for contact information. Proposed modifications to the quarantine regulations address this need [11], but the modifications have been criticized by airlines, public health practitioners, legal experts, privacy advocates, and others. The comment period has passed, and revised modifications are expected soon. There is tremendous potential for mathematical biology and network theory to model and understand better the role of air travel and the impact of interventions on the spread of specific diseases such as pandemic influenza [12, 13]. Current models suggest that the impact of travel restrictions will be modest at best. Modeling can be very useful in understanding complex systems and in identifying areas of uncertainty, but these will have to inform, not replace, careful epidemiological and biological investigation.
  12 in total

1.  Probable transmission of norovirus on an airplane.

Authors:  Marc-Alain Widdowson; Roger Glass; Steve Monroe; R Suzanne Beard; John W Bateman; Perrianne Lurie; Caroline Johnson
Journal:  JAMA       Date:  2005-04-20       Impact factor: 56.272

2.  Will travel restrictions control the international spread of pandemic influenza?

Authors:  T Déirdre Hollingsworth; Neil M Ferguson; Roy M Anderson
Journal:  Nat Med       Date:  2006-05       Impact factor: 53.440

3.  An outbreak of influenza aboard a commercial airliner.

Authors:  M R Moser; T R Bender; H S Margolis; G R Noble; A P Kendal; D G Ritter
Journal:  Am J Epidemiol       Date:  1979-07       Impact factor: 4.897

4.  An outbreak of cholera from food served on an international aircraft.

Authors:  J Eberhart-Phillips; R E Besser; M P Tormey; D Koo; D Feikin; M R Araneta; J Wells; L Kilman; G W Rutherford; P M Griffin; R Baron; L Mascola
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

5.  Ticket to ride: spreading germs a mile high.

Authors:  David Ozonoff; Lewis Pepper
Journal:  Lancet       Date:  2005 Mar 12-18       Impact factor: 79.321

6.  Transmission of the severe acute respiratory syndrome on aircraft.

Authors:  Sonja J Olsen; Hsiao-Ling Chang; Terence Yung-Yan Cheung; Antony Fai-Yu Tang; Tamara L Fisk; Steven Peng-Lim Ooi; Hung-Wei Kuo; Donald Dah-Shyong Jiang; Kow-Tong Chen; Jim Lando; Kwo-Hsiung Hsu; Tzay-Jinn Chen; Scott F Dowell
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

7.  Mitigation strategies for pandemic influenza in the United States.

Authors:  Timothy C Germann; Kai Kadau; Ira M Longini; Catherine A Macken
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

8.  Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States.

Authors:  John S Brownstein; Cecily J Wolfe; Kenneth D Mandl
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

Review 9.  Respiratory infections during air travel.

Authors:  K Leder; D Newman
Journal:  Intern Med J       Date:  2005-01       Impact factor: 2.048

Review 10.  Transmission of infectious diseases during commercial air travel.

Authors:  Alexandra Mangili; Mark A Gendreau
Journal:  Lancet       Date:  2005 Mar 12-18       Impact factor: 79.321

View more
  9 in total

1.  Considerations for Use of Investigational Drugs in Public Health Emergencies.

Authors:  Matthew Carl Kirchoff; Jerome F Pierson
Journal:  Ther Innov Regul Sci       Date:  2016-01-01       Impact factor: 1.778

2.  Loss of life expectancy due to respiratory infectious diseases: findings from the global burden of disease study in 195 countries and territories 1990-2017.

Authors:  Guogui Huang; Fei Guo
Journal:  J Popul Res (Canberra)       Date:  2022-02-07

3.  High Sensitivity, Rapid Detection of Virus in High Traffic Environments.

Authors:  Lauren Waller; Zhilin Guo; Rui Tang; Zunming Zhang; Edward Wang; Jarred Yasuhara-Bell; Louise Laurent; Yu-Hwa Lo
Journal:  Front Bioeng Biotechnol       Date:  2022-03-24

Review 4.  Guidelines, law, and governance: disconnects in the global control of airline-associated infectious diseases.

Authors:  Andrea Grout; Natasha Howard; Richard Coker; Elizabeth M Speakman
Journal:  Lancet Infect Dis       Date:  2017-02-01       Impact factor: 25.071

Review 5.  Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa.

Authors:  M A Oke; F J Afolabi; O O Oyeleke; T A Kilani; A R Adeosun; A A Olanbiwoninu; E A Adebayo
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

Review 6.  Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges.

Authors:  Nicholas Israel Nii-Trebi
Journal:  Biomed Res Int       Date:  2017-02-13       Impact factor: 3.411

7.  U.S. airport entry screening in response to pandemic influenza: modeling and analysis.

Authors:  John D Malone; Robert Brigantic; George A Muller; Ashok Gadgil; Woody Delp; Benjamin H McMahon; Russell Lee; Jim Kulesz; F Matthew Mihelic
Journal:  Travel Med Infect Dis       Date:  2009-04-14       Impact factor: 6.211

8.  State-of-the-art methods for studying air distributions in commercial airliner cabins.

Authors:  Wei Liu; Sagnik Mazumdar; Zhao Zhang; Stephane B Poussou; Junjie Liu; Chao-Hsin Lin; Qingyan Chen
Journal:  Build Environ       Date:  2011-07-18       Impact factor: 6.456

9.  Of plagues, planes and politics: Controlling the global spread of infectious diseases by air.

Authors:  Lucy Budd; Tim Brown
Journal:  Polit Geogr       Date:  2009-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.